Expression of Interferon-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma

Our pre-clinical and clinical trials using a replication-defective adenoviral vector expressing IFN-β have shown promising results for the treatment of malignant mesothelioma. Based on the hypotheses that a replication-competent Vesicular Stomatitis Virus (VSV) oncolytic vector would transduce more...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Willmon, Candice L., Saloura, Vassiliki, Fridlender, Zvi G., Wongthida, Phonphimon, Diaz, Rosa Maria, Thompson, Jill, Kottke, Timothy, Federspiel, Mark, Barber, Glen, Albelda, Steven M., Vile, Richard G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891512/
https://ncbi.nlm.nih.gov/pubmed/19773437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-1013
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak